Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 16INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Breast 2

Conditions

Mucositis 27Opioid-Induced Constipation 20Constipation 18Head and Neck Neoplasms 14Stomatitis 13Pain 12Neoplasms 7Obesity 6Intestinal Diseases 5Bronchiolitis Obliterans Syndrome 5Oral Ulcer 3Lymphoma, Follicular 3Hematologic Neoplasms 3Chemotherapy-induced Peripheral Neuropathy 3Breast Neoplasms 3Xerostomia 2Venous Thromboembolism 2Tumor Lysis Syndrome 2Thrombocytopenia 2Teratogenesis 2Sexual Dysfunctions, Psychological 2Sexual Dysfunction, Physiological 2Renal Insufficiency 2Prostatic Neoplasms 2Peripheral Nervous System Diseases 2Overweight 2Obesity, Morbid 2Neutropenia 2Myocardial Infarction 2Myelodysplastic Syndromes 2

Interventions

Testosterone Propionate 1Phenylephrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Sexual Dysfunctions, Psychological × Other × Clear all
NCT00612742 2021-10-29

BLOOM

BioSante Pharmaceuticals

Phase 3 Completed
3,656 enrolled
BreastOther

Breast Neoplasms, Sexual Dysfunctions, Psychological

NCT03592121 2020-03-12

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

Applied Biology, Inc.

Phase EARLY_PHASE1 Completed
3 enrolled 6 charts
BreastOther

Breast Neoplasms, Sexual Dysfunction, Physiological, Sexual Dysfunctions, Psychological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡